Infectious Disease, Respirology
Short and Long-Acting Monoclonal Antibodies for RSV Immunoprophylaxis
This is a 60-minute CFPC Mainpro+ certified eCME program for Canadian HCPs. The goal is to provide education on the
burden of respiratory syncytial virus (RSV) and guidance on RSV prevention and
control measures. This program is designed to provide practical information on
the monoclonal antibodies authorized for RSV prophylaxis in Canada, including a
new long-acting monoclonal antibody for all infants.
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
1.0
ACCREDITATION
Mainpro+
EXPIRY DATE
2024-09-28
This is a 60-minute CFPC Mainpro+ certified eCME program for Canadian HCPs. The goal is to provide education on the burden of respiratory syncytial virus (RSV) and guidance on RSV prevention and control measures. This program is designed to provide practical information on the monoclonal antibodies authorized for RSV prophylaxis in Canada, including a new long-acting monoclonal antibody for all infants.
This program has received an unrestricted educational grant or in-kind support from Sanofi.
Faculty
Cora Constantinescu, MD, FRPCPC
Vivien Brown, MDCM, CCFP, FCFP, NCMP
Christine Palmay, MD, CCFP
Sofia Nastis, MD, CCFP
Learning objectives
Upon completion of this continuing education, program participants will be better able to:
- Recognize the prevalence and burden of RSV disease in all infants
- Explain the role of monoclonal antibodies for protection against preventable disease
- Apply approved RSV immunoprophylaxis in clinical practice
- Employ strategies to discuss RSV immunoprophylaxis for all infants and children
Accreditation
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1.0 Mainpro+ Credit.
Cert+ Program ID#: 200723